Drug Shortage Report for PDP-ERYTHROMYCIN

Last updated on 2021-05-22 History
Report ID 62835
Drug Identification Number 01912755
Brand name PDP-ERYTHROMYCIN
Common or Proper name pdp-ERYTHROMYCIN 5mg/g OINT OPH 50X1g UD
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 5MG
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 50x1g
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-02
Actual start date 2018-10-02
Estimated end date 2021-05-21
Actual end date 2021-05-21
Shortage status Resolved
Updated date 2021-05-22
Company comments KINDLY NOTE THAT THE 3.5G FORMAT IS AVAILABLE
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v48 2021-05-22 English Compare
v47 2021-05-21 French Compare
v46 2021-05-21 English Compare
v45 2021-05-17 French Compare
v44 2021-05-17 English Compare
v43 2021-04-22 French Compare
v42 2021-04-22 English Compare
v41 2021-02-12 French Compare
v40 2021-02-12 English Compare
v39 2021-02-12 French Compare
v38 2021-02-12 English Compare
v37 2021-01-18 French Compare
v36 2021-01-18 English Compare
v35 2020-11-18 French Compare
v34 2020-11-18 English Compare
v33 2020-11-18 English Compare
v32 2020-05-19 French Compare
v31 2020-05-19 English Compare
v30 2020-03-05 French Compare
v29 2020-03-05 English Compare

Showing 1 to 20 of 48